Diabetes News

Endocrinology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Iwase M et al. - Nateglinide may ameliorate hypoadiponectinemia as well as postprandial hyperglycemia in patients with type 2 diabetes mellitus.

Related Articles

16-year excess all-cause mortality of newly diagnosed type 2 diabetic patients: a cohort study
BMC Public Health, 11/17/09    Relevance Score: 89%

Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes
Vascular Health and Risk Management, 10/29/09    Relevance Score: 89%

Achilles tendon volume in type 2 Diabetic Patients with or without Peripheral Neuropathy: MRI Study
Experimental and Clinical Endocrinology & Diabetes, 10/23/09    Relevance Score: 89%

Soy-Protein Consumption and Kidney-Related Biomarkers Among Type 2 Diabetics: A Crossover, Randomized Clinical Trial
Journal of Renal Nutrition, 10/13/09    Relevance Score: 89%

Beta cell (dys)function in non-diabetic offspring of diabetic patients
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 10/12/09    Relevance Score: 89%

Today in Pharmacology/kinetics...keeping you current

Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Lipids in Health and Disease, 12/18/09

New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09

Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
International Journal of Women's Health, 12/18/09